Handwriting Interventions for People With Parkinson's
Launched by OXFORD BROOKES UNIVERSITY · Dec 6, 2017
Trial Information
Current as of August 11, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years old
- • Diagnosis of idiopathic Parkinson's disease
- • A score of ≤3 on the Hoehn and Yahr scale
- • Self-reported problem with handwriting (≥1 UPDRSII, 2.7)
- • Able to communicate in Italian
- • Following a stable medication regimen (no changes in the last 2 weeks and anticipated changes for the course of the study).
- Exclusion Criteria:
- • Severe depression or psychosis (history of),
- • reduced cognition that would preclude active involvement or capacity to consent (according to stages outlined in metal capacity act (ie trigger, information, existing diagnosis, functional test))
- • Orthopaedic, neurological or other condition that significantly impairs hand function,
- • Pregnancy
About Oxford Brookes University
Oxford Brookes University is a leading UK institution known for its commitment to innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, the university actively engages in various clinical trials aimed at advancing healthcare and improving patient outcomes. Leveraging its research expertise and state-of-the-art facilities, Oxford Brookes University fosters a dynamic environment for the development of novel therapies and interventions, contributing to the broader scientific community while prioritizing ethical standards and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Darfo Boario Terme, Brescia, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials